Recent Articles from Investor Brand Network

Mullen Automotive (NASDAQ: MULN), an electric vehicle manufacturer, announced it has executed a settlement agreement with GEM Yield Bahamas Limited and GEM Global Yield LLC SCS, resolving a four-year legal dispute. Under the agreement, GEM has a 55-day due diligence period—subject to extension—to evaluate the transfer of Mullen’s Mishawaka assets in full satisfaction of the judgment. All collection activities will be suspended during this period. Mullen stated it remains focused on expanding its Tunica, Mississippi, manufacturing operations to meet growing demand across its EV product lines.

Sekur Private Data (CSE: SKUR) (OTCQB: SWISF) (FSE: GDT0), a Swiss-hosted cybersecurity and private communications platform, has initiated discussions with multiple referral partners to launch its privacy-focused solutions across several African countries. The move targets enterprise and government clients, especially in high-risk sectors such as education, telecom, and public administration, in response to the continent’s growing exposure to cyber threats. Sekur’s communications suite, which includes encrypted email, messaging, and VPN services, will soon feature multi-tiered authorization for added enterprise security. All services are hosted in Switzerland under strict federal data protection laws, supporting Sekur’s commitment to global privacy standards.

The largest contract electronics manufacturer in the world has teamed up with Mitsubishi to develop and manufacture electric cars for the Japanese automaker. Foxconn, also referred to as Hon Hai Technology Group, has been seeking opportunities to enter the burgeoning electric vehicle sector for quite some time. The world-leading electronics manufacturer now appears to have completed its years-long quest to enter electric vehicle development.

A recent report by energy technology company Baker Hughes reveals that U.S. energy firms have slashed the number of active oil and natural gas rigs to their lowest levels since the beginning of the year. According to the report, the number of oil rigs fell to 474, while natural gas rigs remained unchanged.

A recently conducted study has found a strong link between the intake of ultra-processed foods (UPFs) and a higher risk of developing psoriasis. The findings of this research appeared in the Nutrients journal.

European fashion e-commerce giant Zalando is using generative AI to create images for its website and app more quickly, reflecting how artificial intelligence is changing the fashion industry and helping businesses cut costs.

FAVO Capital (OTC: FAVO), a private credit firm focused on merchant cash advances and revenue-based financing for underserved SMBs, announced the voluntary conversion of all outstanding Super Voting Series C Preferred Shares into common stock. The move simplifies the company’s capital structure, eliminates super voting rights, and aligns with public market governance standards as FAVO continues its preparations for a planned uplisting to the Nasdaq Capital Market. CEO Vincent Napolitano said the decision reflects FAVO’s commitment to transparency, best practices, and long-term value creation for shareholders.

ONAR (OTCQB: ONAR), a global marketing technology firm specializing in AI-driven solutions for revenue acceleration, has selected IBN to lead its corporate communications initiatives. ONAR, which operates across performance, healthcare, and experiential marketing, aims to redefine middle-market marketing through innovation and strategic acquisitions. The company is rapidly growing its global footprint and integrating specialized agencies under one brand to deliver superior client outcomes. Through this partnership, IBN will deploy its expansive distribution network—including 5,000+ syndication outlets and millions of followers across 70+ brands—to amplify ONAR’s visibility among investors and the broader market.

Oragenics (NYSE American: OGEN) a biotechnology company developing intranasal therapies for brain-related disorders, announced it has received approval from Australia’s Human Research Ethics Committee (“HREC”) to begin a Phase II clinical trial of ONP-002, its proprietary neuroprotective therapy for mild traumatic brain injury (mTBI), or concussion. The clearance enables the company to initiate patient enrollment as early as Q2 2025 at Level 1 trauma emergency departments, where concussed patients are often treated. ONP-002, a non-invasive intranasal formulation, has demonstrated safety in Phase I and efficacy in preclinical models by reducing inflammation, oxidative stress and brain swelling. CEO Janet Huffman said the approval marks a key step toward expanding the ONP-002 program internationally, with enrollment sites also under consideration in New Zealand.

Tonix Pharmaceuticals (NASDAQ: TNXP), a fully-integrated biopharmaceutical company, announced financial results for the first quarter of 2025 and reaffirmed its focus on the anticipated FDA decision for TNX-102 SL, a non-opioid analgesic for fibromyalgia, with a PDUFA goal date of Aug. 15. If approved, it would mark the first new drug class for fibromyalgia in more than 15 years. Tonix also highlighted progress across its pipeline, including positive Phase 1 data for TNX-1500 in kidney transplant rejection and strong preclinical results for TNX-801, a live-virus vaccine targeting mpox and smallpox. The company ended the quarter with $131.7 million in cash and cash equivalents and reported a net loss of $16.8 million on $2.4 million in product revenue.

G Mining Ventures Corp. (TSX: GMIN) (OTCQX: GMINF) announced plans to restate its 2024 consolidated financial statements and Management Discussion and Analysis due to two non-cash accounting adjustments totaling approximately $32 million related to IAS 21 foreign exchange treatment. The restatement, which has no impact on the company’s cash position, operations, or financial covenants, reclassifies $11 million in unrealized foreign exchange losses and $21 million in income tax recovery. Net income for Q4 2024 will be restated from $47.6 million to $15.2 million, and basic EPS from $0.21 to $0.07. Revised documents will be filed before the company releases Q1 2025 results on May 14, with a conference call scheduled for May 15.

Intelligent Bio Solutions (Nasdaq: INBS), a medical technology company delivering rapid, non-invasive testing solutions, reported a 20% sequential revenue increase to $728,867 in fiscal Q3 2025, driven by growth in cartridge sales, which now account for 58% of total revenue and strengthen its recurring revenue model. Gross profit surged 91% year-over-year to $341,368, while net loss narrowed by $434,141 to $2.54 million. INBS added 35 new accounts, bringing its active customer base to over 450, and continued expanding internationally through partnerships and multilingual system upgrades. The company also secured its sixth U.S. patent and advanced regulatory efforts across key global markets.

CNS Pharmaceuticals (NASDAQ: CNSP) announced the successful transfer of Orphan Drug Designation from Cortice Biosciences for its lead asset TPI 287, covering gliomas, pediatric neuroblastoma, and progressive supranuclear palsy. TPI 287, a microtubule-stabilizing abeotaxane, has shown potential to cross the blood-brain barrier and demonstrated encouraging results in a Phase 1 glioblastoma trial, including 3 complete and 9 partial responses among 23 evaluable patients. The company plans to initiate a Phase 2 study by year-end 2025 and highlighted the potential benefits of Orphan status, including seven years of market exclusivity upon approval.

SKYX Platforms (NASDAQ: SKYX), doing business as “SKYX Technologies,” announced it will host a corporate update call to review its first quarter 2025 financial results on Wednesday, May 14, at 4:30 p.m. ET. The call will feature Founder and Executive Chairman Rani Kohen, President Steve Schmidt (former CEO of Nielsen Data Corporation and President of Office Depot International), Co-CEO Lenny Sokolow, and CFO Marc Boisseau. The company is known for its disruptive advanced and smart home platform technologies and holds more than 97 issued and pending patents globally, along with a portfolio of over 60 lighting and home décor websites.

NRx Pharmaceuticals (NASDAQ: NRXP) announced that its wholly owned subsidiary, HOPE Therapeutics(TM), has signed a definitive agreement to acquire the Kadima Neuropsychiatry Institute. Kadima, a leading California clinic for interventional psychiatry, offers treatments such as ketamine, Spravato, transcranial magnetic stimulation (TMS), and medication management for CNS disorders including suicidal depression and PTSD. The clinic is profitable and expected to serve as the clinical model for future HOPE clinics. Dr. David Feifel, Kadima’s founder and a nationally recognized leader in interventional psychiatry, will join HOPE as its first Chief Medical Innovation Officer following the closing of the acquisition, which remains subject to customary conditions and financing.

A measure now moving through Pennsylvania’s State House could make cannabis available in stores overseen by the state. On Monday, House Democrats narrowly approved the measure in the Health Committee with a 14-12 vote.

Aegis Capital is pleased to announce its role as the sole book-running manager in the recently completed underwritten public offering for Super League Enterprise, Inc. (NASDAQ: SLE). The offering comprised 5,117,647 shares of common stock at a public offering price of $0.17 per share, resulting in gross proceeds of approximately $869,999 before underwriting fees and expenses. The company also granted Aegis a 45-day overallotment option to purchase up to an additional 767,647 shares, which could increase total gross proceeds to $1 million if fully exercised.

Cannabis Means Business (“CMB”), the industry’s premier business-to-business conference and expo, today shared new details on its schedule of panels and presentations, as well as programming, exhibitions and networking opportunities. The expo will feature a lineup of engaging speakers, including CNBC Fast Money trader Tim Seymour, Philip Wolf, a pioneer of the cannabis hospitality sector. and Dr. Chanda Macias, CEO of Women Grow.

IBN (InvestorBrandNetwork), a multifaceted communications organization committed to connecting companies with the investment community through its dynamic portfolio of 60+ brands, today announced its engagement as the official media partner for DealFlow Events’ inaugural DealFlow Discovery Day on Nuclear Energy . The event is slated to take place on May 22, 2025, at the conveniently located Jay Suites in New York City.

It is very natural to feel immense anxiety and fear after receiving a breast cancer diagnosis. Most people don’t consider seeking second opinions and would rather begin treatment right away. After all, breast cancer is one of the deadliest types of cancer in women, second only to lung cancer in terms of fatalities. The Breast Cancer Research Foundation estimates that slightly over 42,000 women will die from the condition in 2025, making it one of the most prolific killers in the USA.

The year 2024 was a big one for solar power. All around the world, countries worked hard to add new solar energy systems. By the end of the year, nearly 600 gigawatts (GW) of new solar power had been installed. This was a record-breaking number and showed how fast the world is turning to clean energy.

SolarBank (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2), a premier developer and owner of renewable and clean energy projects, specializing in distributed and community solar initiatives throughout Canada and the U.S., has announced a US$100 million project-based financing with infrastructure investor CIM Group to fund a 97 MW portfolio of solar energy projects in the United States. The deal marks a significant step in SolarBank’s evolution from solar developer to long-term asset owner, offering equity-style exposure to U.S. renewable energy growth without issuing new shares ( https://ibn.fm/J7XIZ ).

Nightfood Holdings (OTCQB: NGTF) announced the signing of a Letter of Intent to acquire the 120-room Hilton Garden Inn in Rancho Mirage, California for $36.93 million, marking one of the company’s largest deals to date. The hotel, adjacent to Disney’s Cotino(TM) residential resort community, will serve as a flagship site for Nightfood’s AI-powered Robotics-as-a-Service (“RaaS”) platform, which aims to reduce labor costs and enhance operational efficiency. The acquisition includes plans for a five-room expansion, a $3 million earn-out, and $26.43 million in Series C Preferred Stock, contingent on financial audits, mortgage conditions, and uplisting to a national exchange.

NRx Pharmaceuticals (NASDAQ: NRXP) announced it will release its first quarter 2025 financial results after market close on Thursday, May 15, 2025. The company will host a conference call at 4:30 p.m. ET the same day to discuss the results and provide a corporate update.

IBN, is pleased to announce the latest CryptoCurrencyWire audio production featuring Andrew Gordon, Managing Attorney of Gordon Law Group, a firm that focuses on helping individuals and businesses navigate the intricate world of digital asset taxation, including NFTs and DeFi. In the interview, Gordon outlines key steps for maintaining tax compliance in the crypto space, stressing that investors using multiple exchanges must take responsibility for gathering and organizing all relevant records. He notes that recordkeeping is a basic but crucial element of compliance, especially in a space where standardization across platforms is lacking.

Platinum Group Metals (NYSE American: PLG) (TSX: PTM) announced plans to raise approximately $1.01 million through a private placement of 800,000 common shares at $1.26 per share to major shareholder Hosken Consolidated Investments Limited (“HCI”), pending regulatory approval. The proceeds will support the company’s share of pre-construction activities at the Waterberg Project in South Africa and general corporate needs. The placement price reflects a 3.1% premium to the five-day VWAP on NYSE American as of May 9. Upon completion, HCI will return to a 26% ownership stake. The shares will be subject to a four-month-plus-one-day resale restriction and were offered under exemptions to registration and shareholder approval requirements due to HCI’s related-party status.

Oragenics (NYSE American: OGEN) will host a management update webinar on Tuesday, May 20, 2025, at 4:00 p.m. ET to discuss the unmet medical need in concussion treatment and highlight its lead candidate, ONP-002. The intranasal therapy is currently in a Phase IIa trial for mild traumatic brain injury and has shown promising preclinical results in reducing brain inflammation and swelling. Presenters will include CEO Janet Huffman, CMO Dr. James Kelly, and Chief Clinical Officer Dr. Frank Peacock, a national emergency medicine expert.

NUBURU (NYSE American: BURU) has received a Notice of Noncompliance from NYSE Regulation for failing to meet the $2 million stockholders’ equity requirement under Section 1003(a)(i) of the NYSE American Company Guide, following continued operating losses and a going concern warning in its latest 10-K. The notice does not immediately impact BURU’s trading status, though its ticker now carries a “.BC” designation. The company has until May 29 to submit a plan to regain compliance and until Oct. 29, 2026 to meet the listing standards. Management cited recent strategic initiatives as potential paths to compliance, though their success is not guaranteed.

Copper inventories on the SHFE (Shanghai Futures Exchange) are forecast to further reduce at the end of this week. The quick drop in supplies is expected to trigger a rise in prices, which could incentivize traders to resume shipping the metal to China.

Ucore Rare Metals (TSX.V: UCU) (OTCQX: UURAF) is a critical metals (“CM”) separation technology company executing an ESG-centered plan toward establishing a comprehensive North American critical metals supply chain. The company has developed a transformative commercial-ready technology, RapidSX(TM), for separating and purifying critical metals. Ucore intends to deploy this technology in pursuit of a CM supply chain independent of China for Western original equipment manufacturers (“OEMs”), most notably in the automotive and renewable energy industries.

Quantum BioPharma (NASDAQ: QNTM) announced the completion of dosing in 90-day oral toxicity and toxicokinetic studies for its lead candidate Lucid-21-302 (“Lucid-MS”), a novel treatment in development for multiple sclerosis. The results of these studies will support an Investigational New Drug (IND) application to the U.S. FDA, expected by year-end. Executives highlighted the milestone as a major step toward launching a Phase 2 clinical trial and positioning Lucid-21-302 as a first-in-class therapy for MS.

Wheaton Precious Metals (NYSE: WPM) (TSX: WPM) delivered record quarterly revenue of $470 million in Q1 2025, up 58.5% year over year, driven by a 36% increase in average realized gold equivalent prices and a 16% rise in GEOs sold. Adjusted net earnings rose 53% to $250.8 million, with operating cash flow climbing 64.5% to $361 million. The company declared a 6.5% dividend increase to $0.165 per share and highlighted its robust growth outlook, with four development projects expected to begin production in 2025. Wheaton ended the quarter with $1.1 billion in cash and no debt, supporting its ongoing expansion strategy and capital commitments.

New research shows that using cannabis while pregnant can put both the mother and baby at serious risk. A large-scale review of past studies found links between prenatal cannabis use and problems like low birth weight, premature birth, and even infant death.

Platinum Group Metals (NYSE American: PLG) (TSX: PTM) is advancing the development of its Waterberg Project in South Africa, a large-scale platinum group metals (“PGM”) mine expected to be among the world’s largest and lowest-cost underground operations. In September 2024, an independent definitive feasibility study (“DFS”) was completed for Waterberg, highlighting its robust economics, including projected steady state annual production of 353,208 ounces of platinum, palladium, rhodium and gold, along with significant copper and nickel by-products, over a 54-year mine life. Located in the Bushveld Complex, the project features thick, shallow ore bodies allowing for safer, more efficient mining. Amid rising global demand for PGMs—especially in automotive, electronics, and clean energy sectors—Platinum Group Metals is strategically positioned to meet future market needs.

Calidi Biotherapeutics (NYSE American: CLDI) recently announced promising preclinical results for its innovative RTNova platform, which has successfully delivered transient gene-therapy payloads to targeted tumors. In addition, Calidi’s virotherapy demonstrated efficacy in killing more than 60 different tumor cell lines, showcasing the platform’s potential to revolutionize cancer treatment by enabling both tumor destruction and robust immune activation.

DealFlow Events today announced the launch of the inaugural DealFlow Discovery Day on Nuclear Energy, slated to take place in New York City on May 22, 2025. The event provides a forum for discovering new investment opportunities and exchanging ideas with industry stakeholders including utilities, financiers, site developers, technology providers, and government entities. Especially timely in light of the renaissance in the nuclear energy sector on the back of strong demand for clean energy and the intensive operations of data centers and AI technologies, the event will feature an insights-packed agenda. Thought leaders and top management of companies in the sector will share first-hand perspectives on a variety of pertinent industry topics, including business models, sectoral opportunities and challenges, and avenues of future expansion. The platform provides a unique opportunity for CEOs and senior leadership teams to showcase their companies to professional investors.

NUBURU (NYSE American: BURU) has announced the formation of a strategic working group to revitalize its Blue-Laser Business Unit, aiming to strengthen its position in the defense sector. The move follows a Joint-Pursuit Agreement with a defense-tech partner and plans to introduce vertical applications that enable cross-selling to existing and new clients. NUBURU is also advancing discussions to bring in a senior revenue and marketing strategist, while leveraging AI-driven insights from NexGenAI Solutions Group. The initiative includes the development of a new state-of-the-art operational facility to support this next phase of growth.

Knightscope (NASDAQ: KSCP) has joined the Association for Uncrewed Vehicle Systems International (“AUVSI”), reinforcing its commitment to autonomous security innovation and federal policy leadership. The company will participate in AUVSI’s Cyber, Ground, and Defense Advocacy Committees, including a new Robotics Subcommittee focused on shaping a National Robotics Strategy. Knightscope plans to contribute its expertise in autonomous ground robotics and AI-driven public safety systems to help guide U.S. standards and legislation for uncrewed technologies.

D-Wave Quantum Inc. (NYSE: QBTS) (“D-Wave”), a leader in quantum computing systems, software, and services, posted record first quarter 2025 revenue of $15 million, up 509% from the prior year. Business and financial results for the quarter included the first Advantage annealing quantum computer sale and publication of breakthrough research demonstrating quantum supremacy on a real-world problem.

Last week saw the price of gold hit $3,400 per troy ounce as the dollar saw its value diminish, driven by growing concerns over geopolitical tensions and shifting global trade dynamics. Despite the closure of the London Bullion Market and Shanghai Gold Exchange for May Day celebrations, the rally in gold prices continued worldwide, reflecting increased investor demand for safe haven assets.

For many years, global human development showed consistent progress, and experts from the United Nations had once forecasted that by 2030, people worldwide would experience substantial improvements in their quality of life. However, recent events have changed that outlook. A series of major disruptions—most notably the COVID-19 pandemic—have caused setbacks in development across all parts of the world.

Medulloblastoma is a commonly occurring pediatric brain cancer in kids and adolescents. The cancer develops within the cerebellum, the part of the brain responsible for coordinating movement and other functions. These tumors enlarge quickly, can grow into nearby tissues, and in some cases, can metastasize. The variations in these tumors make it challenging to find appropriate treatments.

German automaker Audi registered a notable increase in vehicle sales in the first quarter of the year, thanks to the growing popularity of its battery electric vehicle (BEV) models. The carmaker’s Q1 2025 earnings report showed revenue of $16.6 billion, a 12.4% increase from Audi’s reported revenue in Q1 2024.

Standard Lithium (NYSE American: SLI) reported Q1 2025 results and highlighted major progress on its flagship Southwest Arkansas Project, including finalizing a $225 million U.S. Department of Energy grant and securing unanimous approval for its first brine production unit. The project was also designated a priority under Executive Order 14241 to boost American mineral production. In partnership with Equinor under the newly branded Smackover Lithium joint venture, the company completed final field-pilot testing with over 99% lithium recovery. With $31.6 million in cash and no debt, the company remains on track for further permitting and royalty approvals in Q2.

Wheaton Precious Metals (NYSE: WPM) (TSX: WPM) has declared its second quarterly cash dividend of 2025 at $0.165 per common share, marking a 6.5% increase over the same quarter last year. The dividend will be paid on or about June 10 to shareholders of record as of May 28, with the ex-dividend date also set for May 28. The company’s Dividend Reinvestment Plan (“DRIP”) remains active, with shares issued through treasury at market price and no discount applied for this quarter.

SolarBank (NASDAQ: SUUN) (CSE: SUNN) has filed a final short form base shelf prospectus with Canadian securities regulators, replacing its previous version set to expire in June 2025. The new Shelf Prospectus allows the company to offer up to C$200 million in securities—including common shares, debt instruments, warrants, and units—over the next 25 months. A corresponding Form F-10 registration has been filed with the U.S. SEC but is not yet effective. Proceeds from any future offerings will support business development, working capital, debt repayment, capital programs, and potential

The opioid crisis remains a critical public health challenge in the U.S. and globally, prompting a series of new regulatory measures designed to improve safety and reduce misuse. In early 2025, the FDA approved Journavx (suzetrigine), a first-in-class non-opioid painkiller offering patients safer alternatives to opioids. Additionally, opioid manufacturers are now required to include prepaid mail-back envelopes for safe disposal of unused medications, while enhanced boxed warnings on opioid labels further reinforce the dangers of misuse, addiction, and overdose.

McEwen Mining (NYSE: MUX) (TSX: MUX) reported Q1 2025 results and outlined growth plans at its Fox Complex, targeting 60,000 ounces of annual gold production by 2027 and a potential expansion to 150,000 ounces by 2030, pending permits. Total annual output could rise to 225,000–255,000 gold equivalent ounces. Backing this plan, the company completed a $110 million convertible note financing. Q1 consolidated production totaled 24,131 GEOs, with improvements expected throughout the year to meet 2025 guidance of 120,000–140,000 GEOs. Gross profit rose to $10.1 million from $6.0 million in Q1 2024, driven by a 31% increase in average realized gold prices. Net loss narrowed to $3.9 million from $20.4 million a year ago. McEwen also confirmed progress at Gold Bar, San José and Grey Fox, and expects to publish a feasibility study on the Los Azules copper project in July.

A survey commissioned by the Secure Energy Project and conducted by research agency Opinium has revealed that most Europeans would rather their countries invest in local clean energy rather than continue importing fossil fuels from the U.S. and Russia. The poll found that Europeans overwhelmingly prefer relying on domestically produced renewable energy, a more reliable and sustainable option, over fossil fuels sourced from abroad.

Venture capital investment in the crypto sector is declining, both in terms of the amount raised and the frequency of deals. The latest data from April shows that instead of a wide spread of smaller investments, there are fewer but much larger funding rounds.

Ford Motor Company has started 2025 on a stronger note, showing signs of progress in its electric vehicle (EV) business. In the first quarter, the company’s Model e division, which focuses on electric cars, recorded a big jump in sales and a smaller financial loss compared to last year.

A recent Canadian study focused on marijuana use among young adults offers insights into which behaviors and personal characteristics are linked to higher risks of marijuana-related problems.

Adageis, a healthcare technology company, is transforming how providers manage insurance payments with its AI-driven software platform, designed to enhance transparency, ensure reimbursement, and support the shift to value-based care. By offering real-time insights into expected payments, identifying reimbursement gaps, and evaluating performance, Adageis empowers clinics—especially smaller or new practices—to optimize revenue, negotiate better insurance contracts, and make informed financial decisions. The platform helps providers navigate complex insurance arrangements while improving profitability, quality, and a focus on patient care. With growing interest in the healthcare technology sector, Adageis stands out as a promising investment opportunity.

Nightfood Holdings (OTCQB: NGTF) is rapidly expanding its footprint in the hospitality and hotel automation sectors through strategic acquisitions, signaling its strong momentum and long-term vision. The company recently closed deals for CarryoutSupplies.com and Skytech Automated Solutions Inc., combining industry leading packaging capabilities with advanced automation technology to enable scalable, efficient solutions. In addition, Nightfood signed a letter of intent to acquire the assets of Victorville Treasure Holdings LLC, owner and operator of a 155-room Holiday Inn(R) in Victorville, California, which is being renovated for rebranding under Courtyard by Marriott(R). With over 130 hotels under management and a growing ecosystem that includes robotic service technology, Nightfood is positioning at the forefront of the hospitality industry’s evolution—aiming to address labor shortages, enhance efficiency, and lead a new era of hospitality and hotel management innovation.

Nicola Mining (TSXV: NIM) (FSE: HLIA) (OTCQB: HUSIF) a junior exploration company with near-term cash flow and district-scale copper potential, has been initiated with an Outperform rating and a price target of C$0.70 (US$0.50) . The coverage highlights Nicola’s diversified asset base, including its flagship New Craigmont Copper Project, the high-grade Treasure Mountain silver-lead-zinc mine, and a 75% economic interest in the Dominion Creek gold project.

D-Wave Quantum Inc. (NYSE: QBTS) (“D-Wave”), a leader in quantum computing systems, software, and services, announced that it will participate in several upcoming investor conferences. These include the Needham Technology, Media & Consumer Virtual Conference on May 9 and 12, the J.P. Morgan Global TMC Conference on May 13 in Boston, the J.P. Morgan Virtual Quantum Conference on May 20, the B. Riley Institutional Investor Conference on May 21 in Los Angeles, the Stifel 2025 Boston Cross Sector Conference on June 3-4, and the ROTH London Conference on June 24-26.

Newton Golf Company (NASDAQ: NWTG) Motion shafts are garnering significant attention for the impressive performance benefits they offer, particularly among players on the Champions Tour. A recent Golf.com article praised the high-quality construction of these shafts and noted that a growing number of golfers competing at the highest levels of senior professional golf are making the switch to Newton’s innovative equipment ( https://ibn.fm/jj5ki ). This surge in popularity highlights Newton Golf’s commitment to pushing the boundaries of golf shaft technology, offering players a more consistent, powerful and reliable swing.

Sekur Private Data (CSE: SKUR) (OTCQB: SWISF) (FSE: GDT0) has initiated a marketing campaign targeting up to 1 million U.S. consumers affected by email data breaches, including a recent incident impacting 1.8 billion Gmail users. The Swiss-hosted cybersecurity company plans to extend its outreach to over 5 million businesses across financial, legal, and real estate sectors. Sekur’s secure communications suite includes encrypted email, messaging, and VPN services, with enterprise features coming soon. The company is positioned in a $14.5 billion market for secure mobile communications projected to reach $88.8 billion by 2032.

TransCode Therapeutics (NASDAQ: RNAZ) announced that the third patient in Cohort 4 of its Phase 1a trial for RNA-based cancer therapeutic TTX-MC138 has been dosed, with 15 patients now treated across four dose levels. The Safety Review Committee approved expanded enrollment and noted no significant toxicities or disease progression to date. Ten patients remain on study, with the longest treated showing stable disease after seven cycles. Early PK/PD data confirm target engagement and support advancing to the Phase 1b dose expansion stage.

A recent report from Bloomberg has made a strong case for allowing Chinese vehicles into the American market. China has made significant strides in the auto sector over the past couple of decades, growing from a country that was almost fully reliant on imported vehicles to one that now dominates the globe in vehicle sales.

New research suggests that a simple examination of the retina could provide an early diagnosis of Parkinson’s disease. Universite Laval researchers conducted this study and their findings appeared in the Neurobiology of Disease journal.

The start of this week saw prices for gold futures increase as safe haven demand by investors, particularly from China, grows. The price of silver also increased, with a weaker dollar index favoring the precious metals markets. May silver prices rose to $32.37 while June gold prices hit $3324.60.

AI is already transforming how we work, and many jobs will eventually be automated . But instead of resisting change or clinging to old methods, it’s time to shift focus. Competing with machines on speed or data processing is a losing battle. The real advantage lies in being more human, not more robotic.

Cybin (NYSE American: CYBN) (NEO: CYBN) a clinical-stage neuropsychiatry company, announced the issuance of U.S. patent 12,291,499 for its CYB003 program targeting major depressive disorder (MDD). The patent covers pharmaceutical compositions and oral dosage forms related to Cybin’s proprietary deuterated psilocin analog and offers exclusivity through 2041. The company is currently dosing patients in a Phase 3 trial and emphasized the importance of strong IP protection as it advances next-generation mental health therapies.

Clene (NASDAQ: CLNN) announced first quarter 2025 financial results and progress on its CNM-Au8 program for ALS and MS. The company is preparing for a potential NDA submission under the FDA’s Accelerated Approval pathway for ALS in Q4 2025, supported by survival data and upcoming biomarker analysis. New data also showed CNM-Au8 significantly improved survival in patients with more severe ALS. In MS, Clene presented Phase 2 extension results demonstrating remyelination and neuronal repair. The company reported a Q1 net loss of $0.8 million on reduced expenses and $9.8 million in cash, funding operations into Q3 2025.

SolarBank (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2), a premier developer and owner of renewable and clean energy projects, specializing in distributed and community solar initiatives throughout Canada and the U.S., announced the development of a new 7.2 megawatt DC ground-mount solar project in upstate New York. The Glor Rd project, as it is known, adds to a string of solar installations that the company is developing across the region ( https://ibn.fm/Z98Pf ).

NanoViricides, Inc. (NYSE American: NNVC) announced approval from the Democratic Republic of Congo’s National Ethics Committee for Health for its planned Phase II clinical trial of NV-387, a broad-spectrum antiviral targeting Mpox (hMPXV). The company is finalizing its Clinical Trial Application for submission to the Ministry of Public Health. NV-387, a host-mimetic antiviral, has shown strong preclinical results across multiple viruses including influenza, RSV, coronaviruses, and orthopoxviruses. NanoViricides sees the therapy as a potential breakthrough for treating viral diseases that evade existing drugs.

Energy Fuels (NYSE American: UUUU) (TSX: EFR) a top U.S. producer of uranium and rare earth elements, reported a net loss of $26.3 million for Q1 2025 on $16.9 million in revenue. Despite the loss, tied to inventory strategy and ramp-up costs, the company boosted its 2025 uranium production guidance to up to 1 million pounds, citing strong grades at the Pinyon Plain mine. Inventory grew to 1.3 million pounds of U₃O₈, while partnerships with Chemours and POSCO advanced Energy Fuels’ U.S.-based rare earth supply chain strategy. The company ended the quarter with over $210 million in working capital and no debt.

McEwen Mining (NYSE: MUX) (TSX: MUX) announced standout drill results from its Fox Complex’s Grey Fox Project, including what the company described as some of the best intercepts yet from the Gibson zone. Highlights include 12.4 g/t gold over 10.7 meters and 4.0 g/t over 30.1 meters, the latter potentially indicating a broad mineralized zone. Drilling at Grey Fox South extended mineralization 250 meters below the existing resource base, while a separate intercept at the 147 Zone returned 48.5 g/t gold over 0.8 meters. A new exploration corridor and promising results near the Whiskey Jack Zone further support resource growth at the site.

Alphabet (NASDAQ: GOOGL) (NASDAQ: GOOG) is one of several tech giants ramping up capital expenditures in 2025 to accelerate artificial intelligence development, reinforcing long-term demand for Nvidia’s AI chips. Alongside Meta, Amazon, and Microsoft, Alphabet is helping drive a projected $300 billion in collective tech infrastructure investment this year. The expanded AI budgets reflect a race to dominate next-gen digital experiences and data center capabilities. For Alphabet, the increased spend strengthens its AI-first approach, including continued development of its Gemini AI model and advanced cloud-based AI services.

Scinai Immunotherapeutics (NASDAQ: SCNI), a biopharma company focused on inflammation and immunology treatments and CDMO services, reported a $4.8 million net gain for 2024, reversing a $6.5 million loss in 2023. The improvement was largely due to $14.8 million in financial income from a loan-to-equity conversion. The company posted $658,000 in revenue—its first ever—from its CDMO unit. R&D expenses remained steady at $5.6 million, while G&A costs dropped to $2.6 million. Cash and equivalents totaled $1.9 million at year-end.

ESGold (CSE: ESAU) (OTCQB: ESAUF), a fully permitted, pre-production resource company on a clear path to near-term gold and silver production, has reported the identification of a significant geophysical anomaly in the southwest portion of its Montauban Project in Quebec. According to a company press release, internal analysis of historical VTEM ( Versatile Time Domain Electromagnetic ) survey data and drill records has highlighted this area as a high-priority exploration target ( https://ibn.fm/1esM9 ).

The Global Solar Council (GSC) is celebrating a decade of progress in the photovoltaic solar energy industry. The industrial body marked its 10th anniversary by encouraging investors and governments to increase their efforts to boost solar energy growth over the next decade. Solar is currently the largest source of renewable energy globally and is poised to play an instrumental role in the transition to clean energy.

The European Union (EU) is preparing to enforce strict new rules targeting money laundering, with major implications for cryptocurrencies. Starting in 2027, privacy-focused digital currencies and anonymous crypto accounts will no longer be allowed under the bloc’s updated anti-money laundering regulations.

ESGold (CSE: ESAU) (OTCQB: ESAUF), a pre-production gold and silver company advancing its fully permitted Montauban Project in Quebec, will present at the Metals Investor Forum in Vancouver on May 9, 2025. The company was invited by Silver Stock Investor author Peter Krauth, who recognized ESGold as a high-potential junior nearing production. ESGold’s presentation, scheduled for 2:50 p.m. PST at the Rosewood Hotel Georgia, will include updates on construction progress and upcoming gold-silver production expected by year-end.